Quintiles has further expanded its global Prime Site network, set up to enhance local infrastructure for clinical trials, by signing up BRANY (Biomedical Research Alliance of New York), a national organisation providing trial-support services to sponsors and investigators in the US.
According to Lindy Jones, senior vice president, Integrated Site Services at Quintiles, the biopharmaceutical services company has been working with BRANY for 14 years and is “continuously impressed with the calibre of their investigator network and the quality of their research”.
BRANY consistently sets and meets “aggressive” start-up timelines for clinical trials, Jones noted. Moreover, the organisation can conduct studies in both hospital and community settings, widening the opportunities for patient participation.
Kimberly Irvine, executive vice president of operations at BRANY, said the alliance would give the organisation’s leading investigators and hospitals “significant opportunities to access industry-sponsored clinical trials”.
End-to-end solution
BRANY’s offering is an expedited ‘end-to-end solution’ for clinical trials that takes in study procurement, budgeting/contracting and ethics assessments by Institutional Review Boards (IRBs).
The Alliance’s Smart Start 60 process comprises a “unique continuum” of clinical trial support services that can get studies up and running in 60 days, compared with typical hospital start-up times of three to six months, BRANY says.
